These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 7885038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hematopoietic growth factor stimulation and cytarabine cytotoxicity in vitro: effects in untreated and relapsed or primary refractory acute myeloid leukemia cells.
    te Boekhorst PA, Löwenberg B, Sonneveld P.
    Leukemia; 1994 Sep; 8(9):1480-6. PubMed ID: 7522289
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of granulocyte-macrophage colony-stimulating factor on the metabolism of arabinosylcytosine triphosphate in blasts during therapy of patients with chronic myelogenous leukemia.
    Gandhi V, Du M, Kantarjian HM, Plunkett W.
    Leukemia; 1994 Sep; 8(9):1463-8. PubMed ID: 8090026
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA, DiCarlo J, Groshek P, Kanakura Y, Berg D, Mayer RJ, Griffin JD.
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [Abstract] [Full Text] [Related]

  • 10. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
    Hiddemann W, Kiehl M, Zühlsdorf M, Busemann C, Schleyer E, Wörmann B, Büchner T.
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
    [Abstract] [Full Text] [Related]

  • 11. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P, Wang C, Curtis JE, McCulloch EA.
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [Abstract] [Full Text] [Related]

  • 12. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P, Wang C, Yang GS, Wang YF, Williams DE, Lyman SD, Minden MD, McCulloch EA.
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers.
    Higashigawa M, Kuwabara H, Cao DC, Hori H, Ohkubo T, Kawasaki H, Ido M, Komada Y, Sakurai M.
    Leuk Lymphoma; 1996 Jul; 22(3-4):279-85. PubMed ID: 8819077
    [Abstract] [Full Text] [Related]

  • 18. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS, Minden MD, McCulloch EA.
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [Abstract] [Full Text] [Related]

  • 19. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
    Bhalla K, Holladay C, Arlin Z, Grant S, Ibrado AM, Jasiok M.
    Blood; 1991 Nov 15; 78(10):2674-9. PubMed ID: 1824260
    [Abstract] [Full Text] [Related]

  • 20. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
    Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K.
    Rinsho Ketsueki; 1993 Jul 15; 34(7):821-8. PubMed ID: 7689660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.